USPTO serial 88081549
IFX 360
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PAQUIN, SAMUEL ROBERT
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IFX 360?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret C. McHugh
MARGARET C. MCHUGH KILPATRICK TOWNSEND & STOCKTON LLPMAILSTOP: IP DOCKETING - 221100 PEACHTREE STREET NE, SUITE 2800ATLANTA, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays for research purposes; biological preparations for use in industry and science, for assay purposes; chemical preparations for scientific assay purposes, other than for medical or veterinary use; chemical reagents for assay purposes, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical test kits for diagnosis, prognosis, and monitoring of autoimmune diseases for laboratory or research use; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary assay purposes; chemical and biological preparations for medical purposes, namely, for diagnosis, prognosis, and monitoring of autoimmune diseases; diagnostic agents, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic biomarker reagents for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, autoimmune diseases; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; none of the aforesaid goods bearing therapeutics | ACTIVE | — |
| 009 | Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of autoantibodies associated with autoimmune diseases; plates, glass slides with one or more sample areas that can be used in chemical analysis, biological analysis, or patterning for scientific, laboratory or medical research use; integrated computerized system for the collection, editing, organizing, modifying, bookmarking, transmission, storage and sharing of data and information related to chemical analyses; computer hardware and software, and diagnostic reagents and controls, for use in diagnosis, prognosis, and monitoring of autoimmune diseases | ACTIVE | — |
| 010 | Medical apparatus and instruments for diagnostic use, namely, instruments for medical diagnostic testing in the field of autoimmune diseases; medical diagnostic instruments for the analysis of body fluids; medical diagnostic equipment for use in diagnosis, prognosis, and monitoring of autoimmune diseases, namely, an automated system consisting of computer-controlled electronic apparatus, computer hardware and software, and diagnostic reagents and controls, for use in diagnosis, prognosis, and monitoring of autoimmune diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIO-RAD LABORATORIES, INC.
- Other trademarks owned by BIO-RAD LABORATORIES, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named IFX 360
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 10, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 9, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 14, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 14, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 31, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2018 | NWAP | NEW APPLICATION ENTERED | — |